Nephrosis: Clinical Trials

3 trials for Nephrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Terminated 3
Phase 21Terminated 1

Follow Nephrosis: new trials by email Literature Review of Nephrosis trials Research Report on Nephrosis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Amiloride in Nephrotic Syndrome
Amiloride, Furosemide - Nephrotic Syndrome, Edema
Phase 3TerminatedUniversity Hospital Tuebingen202020-06-082025-01-14
Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome.
Enoxaparin - Nephrotic Syndrome
Phase 2 / Phase 3TerminatedMilitary Institute od Medicine National Research Institute652015-10-012023-01-30
Randomized Trial Comparing Rituximab Against Mycophenolate Mofetil in Children Wtih Refractory Nephrotic Syndrome
Rituximab, MMF - Frequent Relapsing Nephrotic Syndrome, Steroid Dependent Nephrotic Syndrome
Phase 3TerminatedNationwide Children's Hospital32015-01-012019-03-26

Narrower conditions

Nephrotic Syndrome (3)  ·  Edema (1)  ·  Hypernatremia (1)  ·  Venous Thromboembolism (1)

Broader conditions

Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Cardiovascular Diseases (1)  ·  Embolism and Thrombosis (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Thromboembolism (1)  ·  Vascular Diseases (1)

Interventions

Amiloride (1)  ·  Enoxaparin (1)  ·  Furosemide (1)  ·  Rituximab (1)

Sponsors

Military Institute od Medicine National Research Institute (1)  ·  Nationwide Children's Hospital (1)  ·  University Hospital Tuebingen (1)

Countries

Germany (1)  ·  Poland (1)  ·  United States (1)

Top investigators

Anna Matyjek, MD, PhD (1)  ·  Ferruh Artunc, Prof., MD (1)  ·  Laurence Greenbaum, MD (1)  ·  William Smoyer, MD (1)

Results publications

PMID 34884411, PMID 39513526

NIH funding

2019 (1)